Raymond James & Associates’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$57.5K Hold
11,052
﹤0.01% 3838
2024
Q2
$30.5K Buy
+11,052
New +$27.6K ﹤0.01% 3844
2021
Q3
Sell
-18,264
Closed -$226K 4116
2021
Q2
$226K Buy
+18,264
New +$217K ﹤0.01% 3612

Other funds holding AVAH

Raymond James & Associates's AVAH Position: Q3 2024 in Review

Raymond James & Associates held its Aveanna Healthcare (AVAH) position steady in Q3 2024 at 11,052 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3838.

Raymond James & Associates first reported a position in AVAH in Q2 2021 and has held it in 3 quarters since. The position peaked at $226K in Q2 2021. 93 funds tracked by Wall St. Rank hold AVAH as of Q3 2024.

  • Raymond James & Associates held 11,052 shares of Aveanna Healthcare worth $57.5K as of Q3 2024.
  • Raymond James & Associates left its Aveanna Healthcare share count unchanged in Q3 2024.
  • Aveanna Healthcare made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3838 holding.
  • Raymond James & Associates first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 3 quarters since.
  • Raymond James & Associates's Aveanna Healthcare position peaked at $226K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.